COMMUNIQUÉS West-GlobeNewswire

-
Labviva Automates Chemical Supply Chain for the Life Sciences Industry
26/06/2025 -
Provectus Biopharmaceuticals Announces Publication of Moffitt Cancer Center Research on PV-10 for Head and Neck Cancer
26/06/2025 -
GRI Bio’s GRI-0621 Demonstrates Encouraging Safety Results at Planned Interim 6-Week Analysis in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
26/06/2025 -
Montauk Brewing Celebrates 13 Years of Brewing with Faherty Collaboration and Beach Clean Up with the Surfrider Foundation
26/06/2025 -
Confluent Health Launches Groundbreaking Scholars Program Designed to Eliminate Student Debt for Future Physical Therapists
26/06/2025 -
BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)
26/06/2025 -
Artelo Biosciences Announces $1.425 Million At-the-Market Private Placement Financing
26/06/2025 -
aTyr Pharma to be Added to the Russell 2000® and Russell 3000® Indexes
26/06/2025 -
RAMSAY GENERALE DE SANTE : nomination de Natalie Davis Présidente du Conseil d'Administration 26 juin 2025
26/06/2025 -
Ramsay Generale de Sante : Natalie Davis appointment as Chairwoman of the Board
26/06/2025 -
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
26/06/2025 -
Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer
26/06/2025 -
New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children
26/06/2025 -
Quoin Pharmaceuticals Releases New NETHERTON NOW Video Featuring Professor Jemima Mellerio, International Expert in Genetic Skin Diseases
26/06/2025 -
Ultrack Systems Inc. (OTC: MJLB) Launches “PUR Rx” — A Scalable Digital Healthcare Platform Through Joint Venture with Synergy Health Rx Corp.
26/06/2025 -
Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared
26/06/2025 -
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
26/06/2025 -
Aeroflow Health Launches Five-Year Corporate Philanthropy Program to Invest in Western North Carolina Communities
26/06/2025 -
Baylor Genetics Applauds New Guidance from American Academy of Pediatrics for Genome and Exome Sequencing to be used as First-Tier Tests for Children with Certain Developmental Delays
26/06/2025
Pages